Ramtin Agah - 30 Aug 2021 Form 4 Insider Report for RenovoRx, Inc. (RNXT)

Role: Chief Medical Officer, Director, 10%+ Owner
Signature: /s/ Ramtin Agah MD
Issuer symbol: RNXT
Transactions as of: 30 Aug 2021
Net transactions value: $0
Form type: 4
Filing time: 17 Jun 2022, 16:06:13 UTC
Previous filing: 17 Jun 2022
Next filing: 04 Oct 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	RNXT	Common Stock	Conversion of derivative security		+1,295	+0.13%		976,295	30 Aug 2021	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	RNXT	Convertible Notes	Conversion of derivative security	$0	-1,295	-100%	$0.000000^*	0	30 Aug 2021	Common Stock	1,295		Direct	F1
transaction	RNXT	Warrants (right to buy)	Conversion of derivative security	$0	+1,295		$0.000000	1,295	30 Aug 2021	Common Stock	1,295	$10.80	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Upon the closing of the Issuer's initial public offering, each Convertible Note, plus accrued interest, automatically converted into (i) one share of common stock and (ii) one five-year warrant to purchase one share of common stock at an exercise price equal to $10.80 per share.
F2	The shares of Common Stock underlying the warrant are immediately exercisable.